Cargando…

Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats

BACKGROUND: Parasitic bronchopneumonia in domestic cats in Europe, which can manifest with moderate to severe clinical signs, is frequently caused by Troglostrongylus brevior. Data on epizootiological and clinical relevance of cat troglostrongylosis have been published in the last decade but treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traversa, Donato, Raue, Katharina, Ringeisen, Hannah, Blazejak, Katrin, Bisterfeld, Katrin, Di Cesare, Angela, Colombo, Mariasole, Böhm, Claudia, Strube, Christina, Pollmeier, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862244/ https://www.ncbi.nlm.nih.gov/pubmed/35193656 http://dx.doi.org/10.1186/s13071-022-05185-y

Ejemplares similares

Efficacy of two topical combinations containing emodepside plus praziquantel, and emodepside plus praziquantel plus tigolaner, for the treatment of troglostrongylosis in experimentally infected cats
por: Traversa, Donato, et al.
Publicado: (2022)

Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis
por: Heuer, Lea, et al.
Publicado: (2020)

Efficacy and safety of imidacloprid 10 %/moxidectin 1 % spot-on formulation in the treatment of feline infection by Capillaria aerophila
por: Traversa, Donato, et al.
Publicado: (2012)

Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate(®)) for the treatment of Troglostrongylus brevior in naturally infected cats in a field study in Greece
por: Diakou, Anastasia, et al.
Publicado: (2019)

Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats
por: Otranto, Domenico, et al.
Publicado: (2019)

Efficacy of Bravecto(®) Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats
por: Raue, Katharina, et al.
Publicado: (2021)

Determination of the effect of collars containing 10% w/w imidacloprid and 4.5% w/w flumethrin (Seresto®) on the incidence of Leishmania and other canine vector-borne pathogen infections in Greece
por: Ligda, Panagiota, et al.
Publicado: (2023)

Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid
por: Huang, Hui-Pi, et al.
Publicado: (2013)

Sustained efficacy of collars containing 10% w/w imidacloprid and 4.5% w/w flumethrin (Seresto(®)) in dogs against laboratory challenge with Haemaphysalis longicornis (Neumann, 1901) ticks
por: Meyer, Leon, et al.
Publicado: (2022)

Efficacy of a topical application of Certifect(®) (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis
por: Fourie, Josephus, et al.
Publicado: (2013)

Effect of Therapy by Using Advocate Spot-On Combination (Imidacloprid 10% and Moxidectin 2.5%) on Subcutaneous Dirofilariosis in Dogs
por: Paran, Radmila Dobešová, et al.
Publicado: (2011)

Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis
por: Fourie, Josephus J., et al.
Publicado: (2019)

Pilot study evaluating the efficacy of a topical formulation containing emodepside and praziquantel in the treatment of natural feline troglostrongylosis
por: Traversa, Donato, et al.
Publicado: (2019)

Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
por: Le Sueur, Christophe, et al.
Publicado: (2010)

Field efficacy and safety of Felpreva® (tigolaner, emodepside and praziquantel) spot-on for the treatment of natural ear mite infestations (Otodectes cynotis) and notoedric mange (Notoedres cati) in cats
por: Blazejak, Katrin, et al.
Publicado: (2023)

Pasture rewetting in the context of nature conservation shows no long-term impact on endoparasite infections in sheep and cattle
por: May, Katharina, et al.
Publicado: (2022)

Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing emodepside, praziquantel and tigolaner, in treating cats naturally infested with fleas and/or ticks
por: Cvejić, Dejan, et al.
Publicado: (2022)

Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis
por: Mencke, Norbert, et al.
Publicado: (2023)

Heat pretreatment of canine samples to evaluate efficacy of imidacloprid + moxidectin and doxycycline in heartworm treatment
por: Bendas, Alexandre José Rodrigues, et al.
Publicado: (2017)

Feline Troglostrongylosis: Current Epizootiology, Clinical Features, and Therapeutic Options
por: Crisi, Paolo E., et al.
Publicado: (2018)

Evaluation of a commercial coproantigen immunoassay for the detection of Toxocara cati and Ancylostoma tubaeforme in cats and Uncinaria stenocephala in dogs
por: Hauck, Daniela, et al.
Publicado: (2022)

Determining resolution of Angiostrongylus vasorum in dogs following anthelmintic treatment with an imidacloprid 10 per cent/moxidectin 2.5 per cent spot-on
por: Bird, Louise Elizabeth, et al.
Publicado: (2018)

Efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 Ctenocephalides felis flea strain infesting cats
por: Dryden, Michael W, et al.
Publicado: (2011)

First Feline Case of Otodectosis in the Republic of Korea and Successful Treatment with Imidacloprid/Moxidectin Topical Solution
por: Ahn, Ah-Jin, et al.
Publicado: (2013)

Clinical assessment of heartworm‐infected Beagles treated with a combination of imidacloprid/moxidectin and doxycycline, or untreated
por: Savadelis, Molly D., et al.
Publicado: (2020)

Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study
por: Segev, Gilad, et al.
Publicado: (2018)

Solvatomorphism of Moxidectin
por: Grell, Toni, et al.
Publicado: (2021)

Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
por: Otranto, Domenico, et al.
Publicado: (2021)

Do All Roads Lead to Rome? The Potential of Different Approaches to Diagnose Aelurostrongylus abstrusus Infection in Cats
por: Raue, Katharina, et al.
Publicado: (2021)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats
por: Taenzler, Janina, et al.
Publicado: (2018)

W W cross section and W branching ratios at $\sqrt{s}=183$ GeV
por: Pérez, P
Publicado: (1998)

Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris)
por: Kim, Kyu-Rim, et al.
Publicado: (2012)

Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs
por: Fourie, Josephus J, et al.
Publicado: (2015)

Anthelmintic resistance to ivermectin and moxidectin in gastrointestinal nematodes of cattle in Europe
por: Geurden, Thomas, et al.
Publicado: (2015)

W+W- Event Properties at $\sqrt{s}$ = 183 GeV
por: CERN. Geneva
Publicado: (1998)

W+W- Event Properties at roots=183 GeV
por: CERN. Geneva
Publicado: (1998)

Measurement of triple gauge boson couplings with W+W- ---qqqq and W+W- ---lnln at $\sqrt{s}$=183 GeV
por: CERN. Geneva
Publicado: (1998)

Decay properties of W boson in e^+e^--> W^+W^- events at 183 GeV
por: Metreveli, Z, et al.
Publicado: (1997)

Measurement of R_cW in $e^+e^-$ - W+w- at $\sqrt{s}$ = 183 GeV
por: CERN. Geneva
Publicado: (1998)

Efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with ear mites (Otodectes cynotis)
por: Blazejak, Katrin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b0vrum4vt8gcqp84si5s7abgnn